Sivik Global Healthcare LLC In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 29, 2024), Sivik Global Healthcare LLC reported 37 stock positions worth $223.9 million . Its top holding was Eli Lilly (LLY) at 6.1% of the portfolio, followed by Novo-Nordisk A/S-Spons ADR (NVO, 5.7% ) and McKesson (MCK, 4.7% ). Compared with Q1 2024, it opened 5 new positions, sold out of 14, added to 12 and reduced 16. The biggest buy was a new position in Merck (MRK) and the biggest sale an exit from SS SPDR S&P Biotech ETF (XBI).
Location GREENWICH, CT
CIK 0001596452
Portfolio Value $223.9M (Q2 2024) Holdings 37 stocks · $223.9M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 LLY Eli Lilly & Co. 15,000 $13.6M Reduce -6.3% NVO Novo-Nordisk A/S-Spons ADR 90,000 $12.8M Reduce -2.7% MCK McKesson Corp. 18,000 $10.5M Add +24.1% THC Tenet Healthcare Corp. 70,000 $9.3M Reduce -6.7% BSX Boston Scientific Corp. 115,000 $8.9M Reduce -14.8% SYK Stryker Corp. 25,000 $8.5M No change MRK Merck & Co. Inc. 65,874 $8.2M New HCA HCA Healthcare Inc. 25,000 $8.0M Add +42.9% ISRG Intuitive Surgical Inc. 17,500 $7.8M Reduce -12.5% TMO Thermo Fisher Scientific Inc. 14,000 $7.7M Reduce -9.7% DHR Danaher Corp. 30,000 $7.5M No change UHS Universal Health Services-B 40,000 $7.4M No change VRTX Vertex Pharmaceuticals Inc. 15,000 $7.0M Add +36.4% BIIB Biogen Inc. 30,000 $7.0M Add +199.0% SGRY Surgery Partners Inc. 250,000 $5.9M Add +31.6% CAH Cardinal Health Inc. 60,000 $5.9M Add +33.3% COR Cencora Inc. 26,000 $5.9M New BDX Becton Dickinson and Co. 25,000 $5.8M Add +66.7% RMD Resmed Inc. 30,000 $5.7M Reduce -15.2% EW Edwards Lifesciences Corp. 60,000 $5.5M Reduce -14.3% ACHC Acadia Healthcare Co. Inc. 80,003 $5.4M Add +14.3% AVTR Avantor Inc. 250,000 $5.3M Add +16.9% SEM Select Medical Holdings Corp. 145,000 $5.1M Reduce -27.5% PODD Insulet Corp. 25,000 $5.0M Reduce -16.7% EHC Encompass Health Corp. 55,000 $4.7M Reduce -8.3% A Agilent Technologies Inc. 35,000 $4.5M New WST West Pharmaceutical Services 13,000 $4.3M Add +30.0% SNN Smith & Nephew PLC -Spon ADR 150,000 $3.7M Reduce -26.8% DXCM Dexcom Inc. 30,000 $3.4M Reduce -14.3% BAX Baxter International Inc. 100,000 $3.3M Reduce -23.1% TEVA Teva Pharmaceutical-SP ADR 200,000 $3.3M Add +14.3% NTRA Natera Inc. 30,000 $3.2M Reduce -14.3% MRVI Maravai Lifesciences Hldgs-A 450,000 $3.2M Add +23.3% MEDP Medpace Holdings Inc. 7,500 $3.1M No change HUM Humana Inc. 7,500 $2.8M Reduce -62.5% BRKR Bruker Corp. 40,000 $2.6M New RGEN Repligen Corp. 15,000 $1.9M New
Options reported separately and not counted above: PUT - SPY 100 @ 545 EXP 07/19/2024 puts ($54.5M).
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ XBI SS SPDR S&P Biotech ETF Sold out 0.00% −10.35 CRL Charles River Laboratories Sold out 0.00% −2.46 INSP Inspire Medical Systems Inc. Sold out 0.00% −2.15 ABT Abbott Laboratories Sold out 0.00% −2.07 BMRN Biomarin Pharmaceutical Inc. Sold out 0.00% −1.83 UNH Unitedhealth Group Inc. Sold out 0.00% −1.80 OPCH Option Care Health Inc. Sold out 0.00% −1.34 GEHC GE Healthcare Technology Sold out 0.00% −1.32 CI The Cigna Group Sold out 0.00% −1.32 HUM Humana Inc. Reduce -62.5% 1.25% −1.27 RVTY Revvity Inc. Sold out 0.00% −1.15 CTLT Catalent Inc. Sold out 0.00% −1.03 STVN Stevanato Group SPA Sold out 0.00% −0.97 BNTX Biontech SE-ADR Sold out 0.00% −0.84 BAX Baxter International Inc. Reduce -23.1% 1.49% −0.53 DXCM Dexcom Inc. Reduce -14.3% 1.52% −0.25 SNN Smith & Nephew PLC -Spon ADR Reduce -26.8% 1.66% −0.23 GPCR Structure Therapeutics Inc. Sold out 0.00% −0.07 RMD Resmed Inc. Reduce -15.2% 2.56% +0.02 EW Edwards Lifesciences Corp. Reduce -14.3% 2.47% +0.04 SEM Select Medical Holdings Corp. Reduce -27.5% 2.27% +0.08 TMO Thermo Fisher Scientific Inc. Reduce -9.7% 3.46% +0.18 NTRA Natera Inc. Reduce -14.3% 1.45% +0.29 EHC Encompass Health Corp. Reduce -8.3% 2.11% +0.31 PODD Insulet Corp. Reduce -16.7% 2.25% +0.38 ISRG Intuitive Surgical Inc. Reduce -12.5% 3.48% +0.57 BSX Boston Scientific Corp. Reduce -14.8% 3.95% +0.59 THC Tenet Healthcare Corp. Reduce -6.7% 4.16% +1.29 NVO Novo-Nordisk A/S-Spons ADR Reduce -2.7% 5.74% +1.42 LLY Eli Lilly & Co. Reduce -6.3% 6.06% +1.54
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ MRK Merck & Co. Inc. New 3.64% +3.64 COR Cencora Inc. New 2.62% +2.62 BIIB Biogen Inc. Add +199.0% 3.11% +2.32 A Agilent Technologies Inc. New 2.03% +2.03 MCK McKesson Corp. Add +24.1% 4.69% +1.86 VRTX Vertex Pharmaceuticals Inc. Add +36.4% 3.14% +1.47 HCA HCA Healthcare Inc. Add +42.9% 3.59% +1.46 BDX Becton Dickinson and Co. Add +66.7% 2.61% +1.26 BRKR Bruker Corp. New 1.14% +1.14 RGEN Repligen Corp. New 0.84% +0.84 CAH Cardinal Health Inc. Add +33.3% 2.63% +0.80 SGRY Surgery Partners Inc. Add +31.6% 2.66% +0.60 TEVA Teva Pharmaceutical-SP ADR Add +14.3% 1.45% +0.55 WST West Pharmaceutical Services Add +30.0% 1.91% +0.47 ACHC Acadia Healthcare Co. Inc. Add +14.3% 2.41% +0.40 AVTR Avantor Inc. Add +16.9% 2.37% +0.38 MRVI Maravai Lifesciences Hldgs-A Add +23.3% 1.44% +0.29
Options Activity Q1 2024 → Q2 2024 Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q1 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q4 2025 41 $204.8M XBI, LLY, THC, MCK, HCA Q3 2025 35 $190.5M XBI, LLY, HCA, THC, DHR Q2 2025 38 $223.6M XBI, THC, HCA, MCK, UHS Q1 2025 29 $182.9M XBI, BSX, THC, HCA, LLY Q4 2024 36 $180.8M XBI, LLY, BSX, MCK, SYK Q3 2024 33 $234.6M XBI, LLY, THC, NVO, UHS Q2 2024 37 $223.9M LLY, NVO, MCK, THC, BSX Q1 2024 46 $275.1M XBI, LLY, NVO, BSX, TMO